Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.87 |
| ▸ | MEN1 | O00255 | 1/20 | 0.87 |
| ▸ | ABL1 | P00519 | 1/20 | 0.87 |
| ▸ | LMNA | P02545 | 1/20 | 0.87 |
| ▸ | PKM | P14618 | 1/20 | 0.87 |
| ▸ | IDE | P14735 | 1/20 | 0.87 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.87 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.87 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.87 |
| ▸ | HLCS | P50747 | 6/20 | 0.75 |
| ▸ | CA12 | O43570 | 5/20 | 0.51 |
| ▸ | CA1 | P00915 | 5/20 | 0.51 |
| ▸ | CA2 | P00918 | 5/20 | 0.51 |
| ▸ | CA9 | Q16790 | 5/20 | 0.51 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL8651197 | 0.97 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL27671459 | 0.97 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL6033491 | 0.97 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL8672968 | 0.96 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Stearic Acid SCHEMBL10828834 | 0.95 | TDP1 (0.83) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL6704836 | 0.95 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL28172151 | 0.94 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL22835070 | 0.94 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23055065 | 0.93 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL21981206 | 0.93 | TDP1 (1.00) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307662-A | Bifunctional protein and detection kit containing same | 科美诊断技术股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-112334776-B | Hybridization of full LNA oligonucleotides | 豪夫迈·罗氏有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-110577547-B | Synthesis method of biotin intermediate | 浙江工业大学 | 2021-05-11 | — | — | CN | disclosed |
| CN-110577547-A | Synthesis method of biotin intermediate | 浙江工业大学 | 2019-12-17 | — | — | CN | disclosed |
| US-8993714-B2 | Streptavidin macromolecular adaptor and complexes thereof | IMIPLEX LLC (US) | 2015-03-31 | — | — | US | disclosed |
| US-20100329930-A1 | STREPTAVIDIN MACROMOLECULAR ADAPTOR AND COMPLEXES THEREOF | IMIPLEX LLC (US) | 2010-12-30 | — | — | US | disclosed |
| US-20100256342-A1 | PROTEIN NODES FOR CONTROLLED NANOSCALE ASSEMBLY | SALEMME FRANCIS RAYMOND | 2010-10-07 | — | — | US | disclosed |
| WO-2009055068-A1 | STREPTAVIDIN MACROMOLECULAR ADAPTOR AND COMPLEXES THEREOF | IMIPLEX LLC (US) | 2009-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256342-A1 | PROTEIN NODES FOR CONTROLLED NANOSCALE ASSEMBLY | STAMBP, NUP93, DENR | TDP1 3833/4885MEN1 2498/4885ABL1 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.